Bioscience, applied to the skin
Leadership
Deep, specialized expertise in dermatology, inflammation and immunology
Leadership
President and CEO
Chief Medical Officer
Chief Technical Officer
Chief Financial Officer
Vice President, Clinical Development
Vice President, Finance
Vice President, Clinical Operations
Vice President, Regulatory Affairs
Board of Directors
Co-Founder and Chairman of the Board
President and CEO
Scientific Advisors
Strategic Collaborations
Arcutis and AstraZeneca have entered into a licensing agreement for exclusive worldwide rights to all topical dermatological uses of roflumilast.
Arcutis and Jiangsu Hengrui Medicine Company of China executed an option agreement for an exclusive license to the active pharmaceutical ingredient in ARQ-250 for all topical dermatological uses in the United States, Europe and Japan.